| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Operating Officer +2 more
2 companies
Klein Matthew B. is a Chief Executive Officer at PTCT, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 39 sales. Those positions are worth an estimated $26.9M at current prices.
Our model assigns Klein Matthew B. a middling insider score of 54/100, based on 27 past trades. Over a 12-month horizon, 31.6% of those trades were profitable, with an average 12-month return of -27.8%.
Klein Matthew B.'s largest disclosed position is in PTCT as Chief Executive Officer, worth about $26.3M. The recent filings there lean toward selling, a net 138,873 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 4,517 | $43.64 | $197,129.42 | -5.5% | +6.1% | -37.1% | |
| Jan 9, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 731 | $41.66 | $30,450.68 | -0.9% | +16.9% | -31.0% | |
| Apr 19, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 897 | $42.52 | $38,135.96 | -1.6% | -0.3% | +22.2% | |
| Jan 7, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Operating Officer | Sell | 775 | $38.53 | $29,856.88 | -4.5% | +12.9% | +3.2% | |
| Apr 20, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sell | 2,500 | $47.23 | $118,080.76 | -12.9% | -9.5% | -7.7% | |
| Jan 15, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 4,300 | $69.09 | $297,078.40 | -18.2% | - | - | |
| Jan 8, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 5,500 | $69.71 | $383,410.00 | -22.2% | - | - | |
| Jan 7, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 3,886 | $68.98 | $268,056.28 | -16.8% | - | - |